Clinical trials: Arterial Embolization
Benign Prostatic Hyperplasia
Embozene® Microspheres for Prostatic Arterial Embolization in Patients With Symptomatic Benign Prostatic Hyperplasia
The purpose of this observational study is to evaluate the prostatic arterial embolization (PAE) with Embozene® Microspheres (Boston Scientific) in sphere sizes of 250 µm for the treatment of symptomatic benign prostatic…
- Trial name
- EmboProstate (NCT02206243)
- Testing
- Embozene Microspheres
- Where
- Germany
- Volunteers
- 300 people
- Sponsor
- Jena University Hospital